The Breakdown of Skeletal Muscle in Dairy Cows During Peak Lactation by Gray, Tarra Stacee
 
 
 
http://waikato.researchgateway.ac.nz/ 
 
 
Research Commons at the University of Waikato 
 
Copyright Statement: 
The digital copy of this thesis is protected by the Copyright Act 1994 (New Zealand). 
The thesis may be consulted by you, provided you comply with the provisions of the Act 
and the following conditions of use:  
 Any use you make of these documents or images must be for research or private 
study purposes only, and you may not make them available to any other person.  
 Authors control the copyright of their thesis. You will recognise the author’s right to 
be identified as the author of the thesis, and due acknowledgement will be made to 
the author where appropriate.  
 You will obtain the author’s permission before publishing any material from the 
thesis.  
 
The Breakdown of Skeletal
Muscle in Dairy Cows During
Peak Lactation
U .The.nlverslty
ofWaiI<ato
A thesissubmittedin partialfulfilment
of the requirementsfortheDegreeof
Master of Science in Biological Sciences
at
The UniversityofWaikato
by
Tarra Stacee Gray
March2008
 For my grandparents 
Lil & Vern 
Inez & Tommy 
Abstract 
The decline in fertility in dairy cows is of international concern. Since 
1950, milk production demands have increased while first service rates of 
conception have decreased. It is unclear why fertility has decreased, however 
current dairy management practice requires cows to be kept on a tight yearly 
calving schedule to ensure maximum milk production over the lifetime of the 
cow. The current postulate suggests that this regime places a high metabolic 
burden on the cows, which in turn requires breakdown of tissues such as fat 
and muscle to provide substrates to meet the increased energy demands of 
lactation. 
 Immediately after calving, dairy cows enter a state of negative 
energy balance (EB), as they cannot consume enough energy to sustain 
lactation. During this period of negative EB, fat is mobilised in the form of non-
esterified fatty acids to help supply the body with the extra energy it needs, 
but fat mobilisation decreases after four weeks while cows remain in a state 
of negative EB for several more weeks. It is unclear whether or not muscle 
breakdown occurs and plays a role in the restoration of EB in lactating dairy 
cows. I hypothesized that the breakdown of muscle does occur in cows 
during peak lactation, and that it occurs to a greater extent in cows producing 
higher amounts of milk.  
 Dairy cows from three strains, NZL, NZH and OSH, representing cows 
with differing milk production abilities (low, intermediate and high, 
respectively), were studied for 12 weeks postpartum. Blood was drawn at 
 i
weekly intervals and muscle biopsies taken at -1, 1, 4, 8, and 12 weeks 
postpartum. 
 Analysis of plasma revealed an increase in the abundance of 
troponin I-fs (a marker of muscle breakdown) over the period of study, 
suggesting that breakdown of skeletal muscle was occurring. Real-time 
polymerase chain reaction analysis showed that expression of the ubiquitin-
proteasome (UbP) ligases atrogin-1 (atro1) and muscle ring finger 1 protein 
(murf1) increased initially, but returned to normal levels by four weeks 
postpartum. Concentration of mRNA of the lysosomal proteases, cathepsin B, 
D, H and L, did not change over the period of study. Therefore, the UbP 
pathway may contribute to the breakdown of muscle detected by troponin I-fs 
in plasma.  
Proteins involved in translation initiation were examined by Western 
blotting. The ratio of phosphorylated over total eIF2α and 4E-BP1 remained 
unchanged throughout the study, indicating that the breakdown of muscle 
was not a result of decreased protein synthesis. However, there was a 
greater ratio of phosphorylated to total eIF2α in NZL cows compared with 
NZH and OSH, suggesting that protein synthesis was less overall in NZL 
cows than other strains. Measurement of myosin heavy chain composition 
indicated there was no change in the abundance of type I and type IIx muscle 
fibres and plasma myostatin levels did not change over the period of study. 
However, the OSH cows had less myostatin in their plasma than the NZL and 
NZH cows, suggesting that there may be inhibition of muscle growth 
occurring in this strain. 
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 The results of this study suggest that breakdown of muscle could be 
important in restoring the EB in high-producing dairy cows during peak 
lactation. Upregulation of the UbP pathway during the first four weeks of 
lactation may contribute to this muscle breakdown. However, it remains 
unclear what processes then continue to regulate breakdown of skeletal 
muscle to maintain the elevated abundance of troponin I-fs in plasma from 
four to 12 weeks postpartum in lactating dairy cows. 
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NEFAs non-esterified fatty acids 
NZH New Zealand high producer 
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O2 oxygen 
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OSH overseas (North American) high producer 
p70S6K S6 kinase 
PCR polymerase chain reaction 
PEG polyethylene glycol 
pH hydrogen ion concentration 
PI3K phosphoinositide 3 kinase 
PVP polyvinylpyrrolidone 
RNA ribonucleic acid 
rpm revolutions per minute 
RT-PCR reverse transcriptase polymerase chain reaction 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
s.e.m. standard error of the mean 
Ser serine 
ss slow skeletal 
TBS tris buffered saline 
TBST tris buffered saline with tween 20 
TEMED N,N,N’,N’-tetra-methyl-ethylenediamine 
TGF-β transforming growth factor-β 
Thimerosal mercury-[(o-carboxyphenyl)thio]ethyl sodium salt 
Thr threonine 
Tris tris(hydroxymethyl)aminomethane 
trop troponin 
Tween 20 polyoxyethylene sorbitan-monolaurate 
U units 
US United States 
UbP ubiquitin-proteasome pathway 
V volt(s) 
 
1. Review of the Literature 
1.1. Fertility in Dairy Cows 
1.1.1. A Steady Decline Over Decades 
There is growing concern internationally with the decline in fertility 
in dairy cows. The most extensive records have come from the United 
States (US) where, in New York state, first-service rates of conception 
have dropped from approximately 65% in 1951 to 40% in 1996 (Butler, 
1998). The steady decline in rates of conception was not well documented 
initially. However, standardised documentation procedures were 
developed and implemented to show the greatest decline occurred after 
the mid-1980s (Lucy, 2001). The underlying cause of the declining fertility 
is unknown. Nevertheless, the trend is proposed to be related to a more 
focussed genetic selection for cows to produce greater yields of milk. In 
doing so, other important traits such as health, fertility and longevity were 
ignored (Weigel, 2006). Reduced fertility in dairy cows has been related to 
shorter oestrous cycles (the phase when an animal is sexually receptive, 
or in heat), shorter duration of oestrus, fewer standing events (receptive 
stance of a cow), as well as recurrent multiple ovulations (McDougall, 
2006; Staples et al., 1990; Weigel, 2006). Nevertheless, the basis of these 
observations could be a consequence of selection for high milk production 
demands (Kadokawa & Martin, 2006).  
The reduced fertility seen in the dairy industry is not evident in the 
beef industry. Beef cows experience reduced fertility only when they are 
undernourished and have lost too much body weight (BWT), resulting in 
poor body condition (Hess et al., 2005; Houghton et al., 1990; Lake et al., 
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2005; Lucy, 2003; Olson, 2005). The reproductive physiology of a 
postpartum cow differs to that of a heifer (in both beef and dairy cows) in 
that the strain of the last pregnancy and lactation render it more difficult for 
a postpartum cow to become pregnant. However, a beef cow with good 
body condition will have a conception rate similar to a heifer (Lucy, 2003). 
In theory, the fertility of postpartum cows should be high if they are 
disease-free and producing normal amounts of milk. Loss of body 
condition in the postpartum period may be a crucial factor in reduced 
fertility. Genetic selection programmes for dairy cows have exploited 
nutrient partitioning to increase milk yield at the expense of BWT 
(McDougall, 2006; Weigel, 2006). In contrast, beef cows have not been 
selected for production of a high milk yield and do not lose BWT or body 
condition during lactation (Hess et al., 2005; Lake et al., 2005; Lucy, 
2003). 
 
1.1.2. An Increased Demand for Milk Production and the  
Metabolic Cost to Fertility 
 
Over the past few decades the consumer demand for milk has 
increased steadily and cows have been genetically selected to meet the 
increased demands. Several studies have shown that there is an inverse 
relationship between milk yield and rate of conception in cows 
(Dematawewa & Berger, 1998; Hansen, 2000; Laben et al., 1982; 
McDougall, 2006). Indeed, it has been suggested that the reproductive 
biology of today’s high milk-producing dairy cow is significantly different to 
that of their ancestor’s (Weigel, 2006). There is a prevalence of abnormal 
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oestrus cycles in cows selected for high milk production, and the duration 
of oestrus is reduced (McDougall, 2006; Nebel & McGilliard, 1993; Butler 
& Smith, 1989).  
Immediately after calving, milk yield increases rapidly, while the 
increase in compensatory feed intake is delayed (Buckley et al., 2003; 
Nebel & McGilliard, 1993). As a result, dairy cows are in a state of 
negative energy balance (EB) during peak lactation and body tissues, 
typically adipose, are mobilized to help the lactating cow meet the energy 
requirements of lactation (Kim & Suh, 2003; Macrae et al., 2006; 
McDougall, 2006; Weigel, 2006). However, the dairy industry requires 
lactating cows to be pregnant by day 85 after calving (see section 1.1.3.) 
to match the length of gestation for a cow to calve and, therefore, produce 
milk annually. 
 
1.1.3. The Annual Calving Schedule  
 
A typical year in the dairy industry has a dairy cow calving once per 
year. The length of gestation in cows is 280 days. Cows spend 
approximately 305 days in lactation, and have a 60 day “dry” period 
(cessation of lactation) (Figure 1.1). During the “dry” period, milking is 
stopped gradually or abruptly, the latter being the preferred method. This 
enables the udder to undergo involution, to repair and regenerate 
secretory tissue, to give the digestive system a rest from the stress of high 
feed intake and to allow the cow to replenish its energy reserves (Capuco 
et al., 1997; Grum et al., 1996). The length and severity of negative EB 
varies depending on the production demands of the cow and extended 
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periods of negative EB may affect fertility (Butler, 1998, 2000; Butler et al., 
1981; Butler & Smith, 1989; de Vries & Veerkamp, 2000; Spicer et al., 
1990; Staples et al., 1990; Veerkamp et al., 1994; Villa-Godoy et al., 
1988). 
 
 
Figure 1.1: Programme followed for year-round calving. 
 
The seasonal calving system used in New Zealand and Ireland is more 
stringent in that calving needs to be timed to coincide with peak pasture 
growth as well as fitting into 365 days (Buckley et al., 2003; McDougall, 
2006). In a representative season, breeding starts on a given day in 
spring. In this way the majority of the herd is calving at the same time, 280 
days later. Breeding programs are established to produce the highest 
pregnancy rate in the shortest amount of time after the start of the 
breeding season in order to establish a tightly regulated calving scedule 
for the following years (Buckley et al., 2003). In a country where cows are 
fed high energy concentrate rations and live in barns, such as the United 
States or Canada, it is not essential to time calving with peak pasture 
growth. 
60 days “dry” 305 days lactation 
85 days to impregnate 280 days gestation 
Year-round calving schedule 
Parturition Parturition 
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The interval from calving to first ovulation is a critical period for the 
dairy industry so that a cow conceives, ideally, at first service (Westwood 
et al., 2002). It is unclear whether or not there is a link between the interval 
from calving to first ovulation and energy state. Some have shown a 
positive relationship between EB during the first few weeks after calving 
and the time to first ovulation (Butler, 2000; Butler et al., 1981; de Vries & 
Veerkamp, 2000; Senatore et al., 1996; Staples et al., 1990). In contrast, 
other groups have not been able to relate EB to length of anoestrus 
(Harrison et al., 1990; Spicer et al., 1990; Villa-Godoy et al., 1988). 
Whether or not EB relates to time to first ovulation when a cow is in a state 
of negative EB, there is reduced secretion of luteinising hormone-releasing 
hormone (LHRH). As a consequence, the reduction in secretion of LHRH 
leads to reduced secretion of luteinising hormone (LH), the principal 
hormone regulating follicular development and ovulation (Lucy, 2003; 
Garnsworthy & Webb, 2000; Zurek et al. 1995). Therefore, ovarian follicles 
fail to reach the pre-ovulatory stage (Butler, 2000). The concentration of 
serum LH increases after the nadir of EB, and first ovulation follows soon 
after (Butler, 2000; Zurek et al., 1995). A likely possibility is that selection 
for high milk production has resulted in an increased requirement for 
energy to support the increased milk production which then compromises 
the reproductive axis, leading to a lower rate of conception, a higher rate 
of embryonic loss and a higher proportion of anoestrous cows (the phase 
when the sexual cycle rests) (Kadokawa & Martin, 2006; Weigel, 2006).  
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 1.2. Body Condition Scoring 
1.2.1. What is Body Condition Scoring? 
 
It is crucial in dairy management to be aware of a cow’s body 
reserve status. Before 1970, there was no simple way to measure the 
energy reserves or body condition of a cow (Roche et al., 2004). Early 
studies were carried out using a Beltsville open-circuit respiration 
chamber, or similar, in which energy consumed (feed, O2, H2O) as well as 
energy expelled (urine, faeces, CO2), were all recorded (Eisemann et al., 
1986; Tyrrell et al., 1988). It was a thorough method allowing valuable 
information to be obtained regarding a cow’s health and condition. 
However, it was very tedious and time-consuming, and not ideal for large 
studies. Body condition scoring (BCS) was developed as a surrogate 
measure of energy status and is used to assess changes in the body 
condition of dairy cattle. It is helpful for both farm management and 
research. A reduction in BCS is associated with the mobilization of fat (de 
Vries & Veerkamp, 2000; Komaragiri et al., 1998), thus it is thought that 
BCS can be used to indicate a cow’s energy state (Kim & Suh, 2003). 
Energy stores can vary as much as 40% in cows with the same BWT 
(Andrew et al., 1994), thus change in BWT alone cannot be used to gauge 
the change in adipose and lean tissue assessed using the BCS system 
(NRC, 2001).  
There are different BCS systems used internationally. The US and 
Ireland use a 5-point scale, Australia uses an 8-point scale and New 
Zealand uses a 10-point scale. Regardless of the scale, a score on the 
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lower end corresponds to a thin, undernourished cow, and a score on the 
high end reflects an obese, overnourished cow. The US and Australia 
assess BCS visually, while Ireland and New Zealand use palpation on the 
back and hind quarters in combination with visual assessment to 
determine BCS (Jones et al., 1982). Roche et al. (2004) examined 
relationships between the different BCS systems to allow studies to be 
compared regardless of the system in place. They found that there were 
strong positive linear relationships between the New Zealand 10-point 
BCS system and the US 5-point, the Irish 5-point and the Australian 8-
point BCS scales. The correlation was much stronger when palpation and 
visual assessments were made, as opposed to just visual. They also 
found that the New Zealand pasture-based system of dairy farming results 
in thinner cows than the other three systems (Roche et al., 2004). Thus 
New Zealand cows are at the lower end of the BCS scale and a 
combination of decreased appetite and/or decreased pasture growth can 
reduce BCS even further. 
 
1.2.2. How Does Body Condition Scoring Relate to Fertility? 
 
Before 1970, it was thought that a cow’s body condition was most 
crucial at calving. However, with the observed loss of body condition 
between calving and the start of breeding, the importance of good body 
condition has extended past calving and into lactation (Beam & Butler, 
1999; Buckley et al., 2003). Several studies suggest that the length of time 
a cow remains in negative EB during lactation correlates negatively with 
conception (Domecq et al., 1997; Nebel & McGilliard, 1993; Villa-Godoy et 
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al., 1988). Butler and Smith (1989) showed that losing as little as 0.5 to 1 
point (on a 5-point scale) in BCS between calving and first service 
decreases the rate of conception at first service from 65% to 53%, and 
losing more than 1 point decreases rate of conception at first service to 
17%. Genetic selection for high milk production has also resulted in a 
genetic trend for lower BCS throughout the period of lactation thus 
compounding the observed decline in fertility (Buckley et al., 2003).  
 
1.3. Food Intake 
Food intake is difficult to measure for an individual cow grazing at 
pasture (Halachmi et al., 2004). However, food intake can be simulated 
using a mathematical model that requires absolute values of feed 
requirements (NRC, 2001), day to day body weight fluctuations and milk 
yield (Halachmi et al., 2004). The diet of a dairy cow can be pasture-
based, concentrate-based, or a combination of both. When the diet is 
based on high-energy concentrates, the amount of food the cow 
consumes is thought to be controlled via nutrient requirements. A pasture-
fed cow consumes grass, which has a low digestible energy concentration 
and thus is digested slowly, physically limiting the intake and preventing 
the cow from reaching its metabolic limit (Forbes, 1970). The amount of 
food an animal will consume varies greatly throughout the different stages 
they go through. For instance, pregnant heifers have been shown to have 
larger appetites and eat more than non-pregnant heifers. However, during 
the last few weeks of pregnancy (the dry-off period) a cow’s appetite 
gradually declines (in both pasture and concentrate-fed cows), then 
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increases a few days before calving and continues to increase steadily 
during lactation (Forbes, 1970). Using genetic correlations between milk 
yield and food intake, it has been calculated that high yielding Holsteins 
(pasture and concentrate-fed) consume less than half what is required to 
meet energy demands to support peak lactation. Therefore, mobilisation of 
tissue must be used to  compensate for insufficient nutrient uptake (Pryce 
et al., 2001; Veerkamp et al., 1994). 
 
1.4. Non-Esterified Fatty Acids  
Triacylglycerols (glycerol esterified with three fatty acids) are a 
source of energy stored as adipose tissue. Non-esterified fatty acids 
(NEFAs) are the free fatty acids released from adipose tissue, found 
circulating in blood and supplying the body with energy in times of need 
(Stryer, 1988). During the last week before calving, there is a decrease in 
food intake, which causes the cow to enter into a state of negative EB. 
This state continues through into early lactation, as cows cannot consume 
as much energy as they require to sustain the high energy demands of 
milk production. The additional energy requirements are met by lipolysis 
and concentrations of NEFAs in blood typically increase a few days before 
calving and peak around calving, then remain higher than prepartum up 
until approximately 12 weeks after calving (Adewuyi et al., 2005; Emery et 
al., 1992; Pushpakumara et al., 2003). NEFAs provide several tissues, 
including muscle, with substrate for energy conversion, production or 
oxidation (Adewuyi et al., 2005; Haemmerle et al. 2002). An increase in 
the concentration of NEFAs in blood, along with a decrease in BCS is an 
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indication of negative EB in postpartum cows (Adewuyi et al., 2005; Emery 
et al., 1992; Jaurena et al., 2005; Pushpakumara et al., 2003). There is an 
immediate metabolic shift from nutrient accumulation to mobilisation of fat 
in order to provide additional energy substrates during the period of 
negative EB in early and peak lactation (Adewuyi et al., 2005; Bauman & 
Currie, 1980). It is well documented that mobilisation of NEFAs from 
adipose tissue during and after calving is characteristic of the transition 
from pregnancy to lactation (Adewuyi et al., 2005; Buckley et al., 2003; 
Pushpakumara et al., 2003; Nebel & McGilliard, 1993; Butler & Smith, 
1989). However, it is not well documented whether or not muscle is 
mobilised to offset the deficit in energy resulting from the inadequacy of 
feed intake together with mobilisation of fat. 
 
1.5. Muscle 
Skeletal muscle is the most abundant tissue in the body, making up 
40-50% of body mass (Kelly et al., 1986). The functional integrity and 
quality of muscle is maintained through the dynamic balance of 
myogenesis, protein synthesis and degradation (Franch & Price, 2005; 
Guttridge, 2004; Kandarian & Jackman, 2006). This balance is controlled 
via several pathways which depend on inter- and intracellular signals. 
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1.5.1 Myogenesis 
 
Myogenesis is the formation of muscle tissue, particularly during 
embryonic development. There are four main myogenic regulatory factors 
(MRFs); MyoD, Myf-5, myogenin and MRF4 (Sabourin & Rudnicki, 2000). 
MRFs belong to a superfamily of basic helix-loop-helix DNA-binding 
transcription factors, and are essential for the proliferation and complete 
development of muscle (Berkes & Tapscott, 2005). It is the MRFs that 
initiate the conversion of fibroblasts into myogenic cells. Postnatal growth 
of muscle occurs via limited fusion of new myoblasts to form myofibres 
(hyperplasia). Increased size of myofibres is supported by recruitment of 
satellite cells, which reside under the basal lamina of skeletal muscle 
(hypertrophy). Because satellite cells only represent 2-7% of nuclei in 
adult myofibres, adult muscle mass is primarily the result of hypertrophy. 
Therefore, it is unlikely that maintenance or breakdown of adult muscle 
mass is via myogenesis.  
 
1.5.2. Muscle Atrophy 
 
Healthy human adults typically synthesize and degrade 300 grams 
of protein each day. Atrophy is a change in muscle resulting from 
conditions of disuse, certain states of disease, fasting, and ageing. 
Regardless of the cause, atrophy results in a decrease in protein content, 
fibre size, production of force, and resistance to fatigue (Jackman & 
Kandarian, 2004). Various factors and signaling pathways are altered 
during atrophy, upsetting the balance of synthesis and degradation. Even 
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a small change in synthesis or degradation can have a big impact on 
muscle mass (Franch & Price, 2005; Kandarian & Jackman, 2006). It is 
unclear at present whether the state of negative EB during peak lactation 
alters the balance of protein synthesis and degradation in skeletal muscle. 
 
1.5.3. Protein Synthesis  
 
Synthesis of muscle protein is mediated by several different factors, 
but it is principally regulated at the level of translation (Dreyer et al., 2008). 
Translation is often controlled by variations in the cellular concentration 
and phosphorylation states of only a few initiation factors (Rhoads, 1993). 
The proteins most directly involved are the eukaryotic initiation factors 
(eIFs), specifically eIF2α and eIF4E, and the S6 kinase (p70S6K). 
The eIF2 complex (made up of eIF2α and eIF2β) binds the initiator 
methionyl-transfer RNA to the native 40S ribosome to form the 43S 
initiation complex (Figure 1.2). When the eIF2α subunit is phosphorylated, 
it binds very tightly to the eIF2β subunit which inhibits the catalytic activity 
of eIF2β, thereby downregulating synthesis (Holcik & Sonenberg, 2005; 
Proud, 2005; Pestova et al., 2001). The eIF4 factors help bind mRNA to 
the 43S initiation complex to make up the 48S initiation complex. Upon 
phosphorylation, eIF4E associates with eIF4G allowing for the recruitment 
of several other initiation factors to form the eIF4F complex, initiating cap-
dependent protein synthesis (Fingar et al., 2002; Gingras et al., 2001). 
Depending on the cellular environment, eIF4E may or may not be bound 
by the eIF4E binding protein 1 (4E-BP1). Unphosphorylated, 4E-BP1 
remains tightly bound to eIF4E, preventing translation initiation via eIF4E. 
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However, phosphorylation changes the conformation of 4E-BP1 
decreasing it’s affinity to eIF4E, resulting in subsequent dissociation and 
allowing initiation of translation through initiation complex formation. 
 
eIF4E
4E-BP1
eIF2α
eIF2
P
4E-BP1
P
eIF2α
mRNA5’
3’
eIF4G
m7GpppN-cap
aa
40S
 
Figure 1.2: The key regulatory components of the eukaryotic translation initiation. 
 
The phosphorylation of 4E-BP1 occurs in response to different 
extracellular stimuli encouraging translation. Phosphorylation of 4E-BP1 
decreases during stress, starvation, infection and other undesirable 
cellular states (Gingras et al., 2001). 
While it is known that activation of p70S6K is regulated by 
phosphoinositide 3 kinase (PI3K) and mammalian target of rapamycin 
(mTOR), and that it plays a role in initiation of translation, synthesis of 
protein and hypertrophy of muscle, its exact location in the signaling 
cascade remains unclear (Brown & Schreiber, 1996; Dreyer et al., 2008; 
Fingar et al., 2002; Gingras et al., 2001). However, it is known that 
phosphorylation of p70S6K correlates with hypertrophy of muscle, while a 
reduction in phosphorylation of p70S6K correlates with atrophy (Dreyer et 
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al., 2008). It has yet to be determined whether or not initiation of 
translation is upregulated or downregulated in skeletal muscle in cows 
during peak lactation. 
 
1.5.4. Muscle Degradation 
 
1.5.4.1. The Ubiquitin-Proteasome Pathway  
 
Atrophy of skeletal muscle occurs in pre-existing muscle fibres such 
that an increase in degradation or decrease in synthesis results in a faster 
rate of proteolysis. There are several degradation pathways that can 
contribute to atrophy. The Ubiquitin-Proteosome (UbP) pathway is a major 
contributor to atrophy of skeletal muscle. The 26S proteosome is a multi-
subunit complex that covalently adds poly-ubiquitin chains to proteins 
(Franch & Price, 2005). Ubiquitin is a small peptide which, when 
polyconjugated to a protein, is used to target that protein for degradation 
by the proteosome. The UbP pathway has three key enzymatic 
components; E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating 
enzymes, and E3 ubiquitin ligases. The E3 ubiquitin ligases give substrate 
specificity. Studies have shown that there is a significant increase in the 
levels of mRNA of genes encoding the components of the UbP pathway 
during atrophy (Cao et al., 2005; Dreyer et al., 2007; Eley & Tisdale, 2007; 
Glass, 2003, 2005; Szewczyk & Jacobson, 2005; Tisdale, 2005). There 
are three E3 ligases uniquely expressed in muscle. They are E3α-II, the 
muscle ring finger 1 protein (murf1) and muscle atrophy F-box protein, 
also referred to as atrogin 1 (atro1) (Franch & Price, 2005; Glass, 2003; 
Jagoe et al., 2002). Murf1 and atro1 are consistently upregulated in most 
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muscle wasting conditions and are widely used as proxy markers of 
muscle wasting (Bodine et al., 2001). However, the UbP pathway cannot 
degrade intact myofibrils, and as such works in conjunction with the 
calcium (Ca2+)-dependent calpains (Koohmaraie, 1992; Solomon & 
Goldberg, 1996; Williams et al., 1999). It has not yet been determined 
whether or not the components of the UbP pathway are upregulated or 
downregulated in skeletal muscle during lactation. 
 
1.5.4.2. The Calcium-Calpain Pathway 
 
Calpains are Ca2+-regulated, non-lysosomal, intracellular cysteine 
proteases that are responsible for the cleavage of specific substrates 
during various stages of the cell cycle (Bartoli & Richard, 2005). There are 
principally three calpains expressed in muscle tissue, the ubiquitous μ- 
and m-calpains, and calpain 3. Skeletal muscle-specific calpain 3 differs 
from the μ- and m-calpains in that it is quite often rapidly degraded itself, 
and during atrophy is downregulated (Herasse et al., 1999). The μ- and m-
calpains are activated by μM and mM concentrations of Ca2+, respectively. 
They have four domains, an N-terminal domain, a domain containing a 
distinct cysteine protease sequence, a connecting domain and a Ca2+-
binding domain (Bartoli & Richard, 2005; Costelli et al., 2005). Calpains 
are normally present in the cytosol in an inactive state as a dimer of an 80 
kDa subunit and a 30 kDa subunit. Calpains are regulated by the 
indogenous protein inhibitor, calpastatin, but the precise mechanisms of 
this regulation are unclear (Bartoli & Richard, 2005; Costelli et al., 2005; 
Goll  et al., 2003; Porn-Ares et al., 1998). However, it is known that an 
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increase in cytosolic Ca2+ concentration causes the calpain 80 kDa subunit 
to dissociate from the 30 kDa subunit and become active. Calpains are 
considered key players in skeletal muscle atrophy as they initiate 
degradation of myofibres (Bartoli & Richard, 2005). However, 
Ca2+-dependent calpains can perform only limited proteolysis, while the 
UbP pathway and the lysosomal pathway execute complete degradation, 
allowing the released amino acids to be recycled (Bartoli & Richard, 2005; 
Costelli et al., 2005; Koohmaraie, 1992; Solomon & Goldberg, 1996; 
Williams et al., 1999). 
 
1.5.4.3. The Lysosomal Pathway  
 
The lysosomal degradation pathway is another contributor to 
muscle breakdown. Lysosomes are membrane-bound vesicles containing 
hydrolysing proteins such as proteases, nucleases and phosphatases in 
an acidic environment (between pH 4-5). Lysosomes are responsible for 
the degradation of a wide range of molecules (Bechet et al., 2005). The 
endoplasmic reticulum and the Golgi are located throughout myofibers of 
all muscle types. They control synthesis and direction of lysosomal 
enzymes. Cathepsins are lysosomal proteases. Most exist as 
prepropeptides and are activated when exposed to the acidic lumen of 
lysosomes (Hasilik, 1992; Turk et al., 2001). There are several cathepsins 
involved in lysosomal degradation. The principal lysosomal proteases are 
cathepsin B, cathepsin H, cathepsin D and cathepsin L (Bechet et al., 
2005; Turk et al., 2001). Although cathepsins are abundantly expressed, 
their proteolytic activity is tissue specific. Cathepsin H targets troponin T 
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(Bechet et al., 2005). Cathepsin B degrades myosin heavy chain, troponin 
T, troponin I and tropomyosin (Schwartz & Bird, 1977). Cathepsin L breaks 
down most myofibrillar proteins, excluding troponin C and tropomyosin 
(Matsukura et al., 1981). Cathepsin D degrades actin and myosin (Bird et 
al., 1981). Although cathepsin L is considered a general marker of 
atrophy, expression of other cathepsins can also increase depending on 
the cause of muscle wasting. Stimulation of the lysosomal pathway 
coincides with stimulation of the UbP pathway, Ca2+-dependent calpains, 
or both during atrophy (Bechet et al., 2005). 
 
1.6. Growth Factors 
1.6.1. Insulin-Like Growth Factor One 
Insulin-like growth factor 1 (IGF-1) is a trophic, mitogenic hormone 
synthesized mainly by the liver and skeletal muscle. It plays an important 
role in embryonic and post-natal growth, carrying out autocrine, paracrine 
or endocrine functions. IGF-1 is expressed in response to growth hormone 
(GH) stimulation and activates two principal intracellular signaling 
pathways, the phosphoinositide 3-kinase (PI3K) pathway and the mitogen-
activated protein kinase (MAPK) pathway, thereby promoting protein 
synthesis (Favier et al., 2008). The fusion of myoblasts into myotubes 
through IGF-1 is mediated by PI3K signaling. PI3K also mediates protein 
and glucose uptake, and resistance to apoptosis. The activation of MAPK 
is necessary for developmental IGF-1 receptor (IGF-1R)-dependent 
myogenesis. Cellular effects of IGF-1 are regulated by the IGF-1R, which 
also plays an essential role in myoblast proliferation and differentiation 
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(Singleton & Feldman, 2001). A connection has been made to the 
deactivation of the IGF-1/PI3K/Akt signaling pathway and an increase in 
proteolysis or an increase in the expression of proteolytic genes 
(Kandarian & Jackman, 2006). In conditions of atrophy, concentrations of 
IGF-1 mRNA decrease, subsequently decreasing the rate of protein 
synthesis (Favier et al., 2008).  
The GH/IGF-1 axis is nutritionally sensitive, and IGF-1 expression 
decreases during underfeeding (Jeanplong et al., 2003). Concentration of 
IGF-1 in plasma is directly related to energy status, and IGF-1 is an 
essential component of ovarian follicular development, as well as 
stimulation of progesterone secretion from luteal cells (Patton et al. 2007; 
Butler, 2000). Increased levels of IGF-1 in plasma during the first two 
weeks of lactation have been linked to a higher rate of conception at first 
service (Patton et al. 2007).  
 
1.6.2. Myostatin  
Myostatin is a negative regulator of skeletal muscle growth and 
belongs to the transforming growth factor-beta (TGF-β) family. Myostatin 
inhibits activation and replication of muscle satellite cells, as well as 
synthesis of DNA and protein, thereby inhibiting myogenesis (McCroskery 
et al., 2003; Taylor et al., 2001). Myostatin is a 375-amino acid protein, 
highly conserved in sequence, expressed in developing and adult skeletal 
muscle (Gonzalez-Cadavid & Bhasin, 2004; McPherron et al., 1997). 
Myostatin is cleaved postranslationally into an N-terminal propeptide and 
the active component, the C-terminal myostatin protein, 110 amino acids 
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in length. Myostatin is secreted and circulates in the blood as a dimer, 
complexed with the propeptide and other related proteins (Gonzalez-
Cadavid & Bhasin, 2004). In the absence of myostatin (myostatin null 
mice), or when naturally occurring mutations are present that render the 
protein inactive (Belgian Blue and Piedmontese cattle), double muscling is 
observed, where animals have up to 50% more muscle mass caused by 
hyperplasia and hypertrophy (Lee & McPherron, 2001; Yang et al., 2001; 
Zhu et al., 2000). Myostatin has also been shown to induce muscle 
wasting in mice when present in excess, suggesting that myostatin plays a 
role in mediating cachexia (Zimmers et al., 2002). In support of this role, 
myostatin expression increases in various conditions of atrophy, such as 
during hindlimb unloading and in HIV-infected men (Carlson et al., 1999; 
Gonzalez-Cadavid & Bhasin, 2004; Gonzalez-Cadavid et al., 1998; Lalani 
et al., 2000; Ma et al., 2003). However, myostatin null mice are more 
susceptible to loss of muscle during unloading (McMahon et al., 2003), 
which suggests that myostatin does not only block myogenesis, but it may 
also play other roles that are important for protecting muscle against 
wasting. Ji et al. (1988) found that myostatin is expressed in the 
tubuloalveolar secretory lobules of porcine lactating mammary glands, and 
postulated that myostatin may have a role in the regulation of gestational 
or lactational mammary gland growth and development. It is presently 
unclear what role myostatin plays during peak lactation. 
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1.7. Markers of Muscle Wasting 
1.7.1. Myosin Heavy Chains 
There are two main contractile proteins responsible for muscle 
contraction, actin and myosin. Actin and myosin polymerize to form 
filaments, the thin and thick filaments, respectively. Myosin is a 
fundamental component of the contractile apparatus in muscle. The 
functional diversity of muscle fibres is due to the various isoforms of 
myosin (Pette & Staron, 2000). Myosin is a hexameric protein with heavy 
and light chains. Myosin heavy chains (MHCs) are encoded by a multi-
gene family (Pette & Staron, 2000; Schiaffino & Reggiani, 1994). There 
are four main MHC isoforms: type I, type IIa, type IIx and type IIb. Type I is 
a slow twitch isoform, while the type IIs are fast twitch isoforms (Schiaffino 
& Reggiani, 1994). Although muscle fibres are often classed as a certain 
type, there is actually a continuum of hybrid fibres between the major fibre 
types (Ennion et al., 1995). MHCs are the most essential protein 
components found in skeletal muscle cells as they control the molecular 
motor and are the most abundant (Cooke, 1995). MHC isoforms are 
approximately 200 kDa, and they can be separated on a polyacrylamide 
gel so that the fraction of each isoform present in a sample of tissue may 
be measured (Talmadge & Roy, 1993). Separation of MHCs has played a 
critical role in establishing relative percentages of fibre types, which has 
been useful in the comprehension of what takes place during various 
conditions and disease states (Kohn & Myburgh, 2006). Some MHCs are 
muscle specific, while others are present in a variety of muscles. Muscle 
atrophy (brought on by various states of disuse) is usually accompanied 
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by changes in the relative abundance of MHC isoforms (Chopard et al., 
2001). Muscles composed of mainly fast-twitch myosin isoforms (MHC IIa, 
IIx and IIb, in order of increasing contraction rate) lose mass and protein 
faster during breakdown of protein than muscles composed mainly of 
slow-twitch isoforms (MHC I) (Brodsky et al., 2004). 
 
1.7.2. Creatine Kinase 
For many years concentrations of creatine kinase (CK) detected in 
blood has been used as an indication of muscle wasting (Adams et al., 
1993; Apple et al., 1988). CK is present in both cardiac and skeletal 
muscle. CK exists as a dimer of 39 to 42 kDa and is abundant in most 
tissues. Muscle-CK mRNA is upregulated during atrophy (Cros et al., 
1999), and there is a release of CK into blood after acute myocardial 
infarction (Apple, 1999a; Adams et al., 1993). Changes in concentration of 
CK in blood has been noted in conditions other than acute myocardial 
infarction such as skeletal muscle damage or injury caused by rigorous 
exercise or disease-induced muscle wasting (Adams et al., 1993; Apple et 
al., 1997). CK is no longer the preferred marker for detecting muscle 
wasting after acute myocardial infarction due to its lack of specificity (it 
does not distinguish between cardiac and skeletal muscle), and a switch 
has been made to detect increased concentrations of cardiac-specific 
troponins to detect acute myocardial infarction (Apple, 1999a, 1999b; Jaffe 
et al., 2000). Measuring skeletal muscle-specific troponins for detecting 
breakdown of skeletal muscle is also becoming more common (Simpson 
et al., 2005; Sorichter et al., 1997). Currently, CK remains the most 
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sensitive marker for early detection, particularly for detecting dystrophic 
conditions where a compromised sarcolemma allows CK to leak into 
blood. Therefore high concentrations of CK are a hallmark of the 
pathology. However, the use of CK may not be as sensitive a marker for 
detecting breakdown of muscle as a skeletal muscle troponin assay would 
be for other types of muscle wasting conditions. 
 
1.7.3. Troponins 
 
In the early 1990s, clinicians began to move away from CK 
analyses as an indication of muscle wasting, such as after acute 
myocardial infarction, and troponin became a more reliable and more 
specific marker for the breakdown of cardiac muscle (Adams et al., 1993; 
Adams et al., 1996; Apple, 1999a, 1999b; Apple et al., 1999; Apple et al., 
1997; Hamm et al., 1997; Jaffe et al., 2000; Katrukha et al., 1998; Wu et 
al., 1998). As muscle fibres degrade, troponins are released into the 
blood. Muscle contraction is regulated by intracellular Ca2+ concentrations 
and is a result of the thick (myosin) and thin (actin) filaments sliding back 
and forth (Takeda, 2005). There are three main regulatory components of 
the skeletal muscle thin filament, actin, tropomyosin and troponin. Actin 
polymerizes into helical filaments and tropomyosin (a coiled-coil dimer) 
associates with each strand of the actin helix such that one tropomyosin 
interacts with seven consecutive actin monomers (Brown & Cohen, 2005; 
Farah & Reinach, 1995; Filatov et al., 1999; Takeda, 2005). Troponin is 
located on the polymerized actin filaments with tropomyosin forming the 
muscle thin filament (Figure 1.3) (Reinach et al., 1997; Takeda, 2005).  
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 tropomyosin 
troponin 
actin 
 
Figure 1.3:  The main regulatory components of the skeletal muscle thin filament 
(Adapted from Takeda, 2005). 
 
Troponin is an essential protein for the regulation of skeletal and cardiac 
muscle contraction (Takeda, 2005). It is made up of three polypeptides, 
each with a specific function. Troponin I is the inhibitory subunit of the 
protein. It inhibits the ATPase activity of actomyosin. Troponin C interacts 
with calcium, which then prevents troponin I inhibition of actomyosin. 
Troponin T allows the binding of troponin to tropomyosin (Filatov et al., 
1999). There are two isoforms of troponin I and T, each with a fast and 
slow twitch form. While it is known that contraction in skeletal and cardiac 
muscle is a result of Ca2+ binding to the troponin C subunit, the precise 
mechanism in which troponin regulates the interactions between myosin 
and actin in the thin filament with respect to muscle contraction remains 
unclear (Brown & Cohen, 2005; Takeda, 2005). Assay of troponin has not 
been used for detection of skeletal muscle breakdown to the extent that 
they have been used for detecting breakdown of cardiac muscle. 
However, assay of concentrations of troponin is gaining popularity as a 
marker of skeletal muscle breakdown (Simpson et al., 2005; Sorichter et 
al., 1997).  
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1.8. Outline of this Study 
 
 Thus far, little work has been done to determine what role muscle 
turnover plays in the period of time cows spend in negative EB. While it is 
known that the breakdown of fat (NEFAs) contributes to restoring EB 
initially, it is still unclear whether or not breakdown of skeletal muscle 
contributes to restoring EB in conjunction with breakdown of fat during 
lactation in dairy cows. 
 
This study aims to: 
(i) Determine whether breakdown of skeletal muscle occurs during 
peak lactation in cows. 
(ii) Determine whether breakdown of skeletal muscle occurs in 
relation to the different yields of milk in different strains of dairy 
cows. 
 
I hypothesize that the breakdown of muscle does occur in cows 
during peak lactation, and that it occurs to a greater extent in cows 
producing higher amounts of milk.  
To asses this hypothesis, three strains of cow with different milk 
production abilities were investigated (see section 2.2.1.). 
 
2. Materials and Methods 
2.1. Materials 
 
All reagents used in this research were of analytical grade or better. All 
water used was de-ionized and ultra-filtered in a milli-Q ultra-filtration 
system. 
2.1.1. Antibodies 
 
Antibodies used and their sources are listed in Table 2.1. 
Table 2.1: Antibodies 
Antibody Product # Source 
Rabbit polyclonal troponin I slow skeletal 20645 Santa Cruz 
Rabbit polyclonal troponin I fast skeletal 20644 Santa Cruz 
Rabbit polyclonal troponin T slow skeletal 28269 Santa Cruz 
Rabbit polyclonal troponin T fast skeletal 20643 Santa Cruz 
Goat polyclonal myostatin 6884 Santa Cruz 
Rabbit monoclonal 4E-BP1 9452 Cell Signaling 
Rabbit polyclonal 4E-BP1 6936 Santa Cruz 
Rabbit polyclonal phospho-4E-BP1 2855 Cell Signaling 
Rabbit polyclonal phospho-4E-BP1 9455 Cell Signaling 
Rabbit polyclonal eIF2α 11386 Santa Cruz 
Rabbit polyclonal phospho-eIF2α AB4837 Sapphire Bioscience 
Rabbit polyclonal eIF4E 13963 Santa Cruz 
Mouse monoclonal eIF4E 9976 Santa Cruz 
Rabbit polyclonal phospho-eIF4E 12885R Santa Cruz 
Rabbit polyclonal p70S6K 9027 Santa Cruz 
Rabbit polyclonal p70S6K  9202 Cell Signaling 
Rabbit polyclonal phospho-p70S6K 7984R Santa Cruz 
Rabbit polyclonal phospho-p70S6K 9205 Cell Signaling 
Rabbit polyclonal α-actin A2066 Sigma Chemical Co. 
Rabbit polyclonal goat P0449 Dakocytomation 
Goat polyclonal rabbit P0448 Dakocytomation 
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 2.1.2. Real-Time PCR Primers 
Primer sequences and information are listed in Table 2.2. All primers were 
supplied by SIGMA Genosis. 
Table 2.2: Primers 
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2.1.3. Common Solutions 
 
Common solutions were routinely made in the lab. Common solutions and 
their composition are listed in Tables 2.3 and 2.4. 
Table 2.3: Common solutions 
Solution Composition 
Low Salt Buffer (LSB) 10 mM HEPES-NaOH 
10 mM MgCl 
5 mM KCl 
0.1 mM EDTA 
0.5% IGEPAL 
0.5% Vanadate 
Made a day prior to use 
Add one complete protease inhibitor cocktail 
tablet per 50 mL immediately before use 
  
 
3X Laemmli Sample Buffer 10% Glycerol 
5% βME 
2% SDS 
62.5 mM Tris, pH 6.8 
0.1% of Bromophenol Blue 
Store at -20 ˚C 
  
 
Transfer Buffer 39 mM Glycine 
48 mM Tris 
20% Methanol 
Store at 4 ˚C 
  
 
Tris buffered saline (TBS) 150 mM NaCl 
20 mM Tris 
Adjust to pH 7.6 and store at 4 °C 
  
 
Tris buffered saline with Tween 
20 (TBST) 
0.1% Tween 20 in TBS 
Store at 4 °C 
  
 
Enhanced Chemiluminescence 
(ECL) Buffer 
20 mM Tris 
Adjust to pH 8.6 and store at 4 ˚C 
  
 
Luminol A 458.33 mg Luminol A in 5 mL DMSO 
  
p-Coumaric acid B 840 mg p-Coumaric acid B in 3 mL DMSO 
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ECL Solution 50 mL ECL Buffer 
120 μL Luminol A 
20 μL p-Coumaric acid B 
16.65 μL 30% H2O2 
  
 
Table 2.4: SDS-PAGE gel compositions 
Acrylamide Percentage Composition 
15% 7.5 mL 1.5 M Tris, pH 8.8 
7 mL Milli-Q H2O 
15 mL 30% Acrylamide-Bis 
300 μL 10% SDS 
150 μL 10% APS 
30 μL TEMED 
  
12% 7.5 mL 1.5 M Tris, pH 8.8 
10 mL Milli-Q H2O 
12 mL 30% Acrylamide-Bis 
300 μL 10% SDS 
150 μL 10% APS 
30 μL TEMED 
  
10% 7.5 mL 1.5 M Tris, pH 8.8 
12 mL Milli-Q H2O 
10 mL 30% Acrylamide-Bis 
300 μL 10% SDS 
150 μL 10% APS 
30 μL TEMED 
  
8% 7.5 mL 1.5 M Tris, pH 8.8 
14 mL Milli-Q H2O 
8 mL 30% Acrylamide-Bis 
300 μL 10% SDS 
150 μL 10% APS 
30 μL TEMED 
  
4% 2.5 mL 0.5 M Tris, pH 8.8 
6 mL Milli-Q H2O 
1.34 mL 30% Acrylamide-Bis 
100 μL 10% SDS 
70 μL 10% APS 
20 μL TEMED 
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 2.1.4. Common Laboratory Chemicals and Reagents 
 
All common chemicals and reagents used and their sources are listed in 
Table 2.5. 
Table 2.5: Chemicals and reagents 
Chemical or Reagent Source 
Bromophenol blue; chloroform; 
ethylenediaminetetra-acetic acid (EDTA); 
hydrochloric acid (HCl); hydrogen peroxide (H2O2); 
magnesium chloride (MgCl); potassium chloride 
(KCl); sodium chloride (NaCl); sodium hydroxide 
(NaOH) 
BDH Chemicals Ltd. 
  
Isopropanol; HPLC grade ethanol; methanol 
(MeOH) 
BioLab Ltd. 
  
30% Acrylamide-bis (N,N’-methylene-bis-
acrylamide); ammonium persulfate (APS); 
coomassie brilliant blue R-250; glycine; sodium 
dodecyl sulfate (SDS); N,N,N’,N’-tetra-methyl-
ethylenediamine (TEMED) 
Bio-Rad Laboratories 
  
Bovine serum albumin (BSA); trizol Invitrogen (Gibco BRL) 
  
Acetic acid; tris(hydroxymethyl)aminomethane 
(Tris) 
J.T.Baker 
  
Goat Immunoglobulins; Rabbit Immunoglobulins Med-Bio Ltd. 
  
2-mercaptoethanol (BME); amino acid standard 
solution; Bicinchoninic acid (BCA); p-Coumaric 
acid; Copper (II) Sulfate; Diethyl pyrocarbonate 
(DEPC); Dimethyl Sulfoxide (DMSO); Glycerol; 
HEPES; IGEPAL; Luminol; Mercury-[(o-
carboxyphenyl)thio]ethyl sodium salt (Thimerosal); 
Polyethylene Glycol (PEG); Polyoxyethylene 
sorbitan-monolaurate (Tween 20); 
Polyvinylpyrrolidone (PVP); Ponceau S; Vanadate 
SIGMA Chemical Co. 
  
Complete protease Inhibitor cocktail Roche 
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2.2. Methods 
2.2.1. Animal Maintenance 
 
The animals used in this project were obtained from Dexcel farms 
or commercial dairy farms in New Zealand. The cows chosen milk 
production recorded and were purebred for more than three generations. 
Three strains were selected, the New Zealand 70 (NZL), New Zealand 90 
(NZH), and North American 90 (OSH). NZL is a strain of NZ Holstein 
Friesian (HF) with high Breeding Worth (a system in which bulls and cows 
are ranked on their expected ability to produce profitable replacements) in 
the 1970s. The NZL strain represented the selection and breeding policies 
in NZ prior to 1970. Livestock Improvement Corporation (LIC) stored 
semen from that time and used it to artificially inseminate dams that 
represented cows in the NZ population in the 1970s selected for high milk 
fat yield. The NZL strain had 7% North American (NA) HF genetics. Both 
sires and dams used to generate this strain had a low proportion of NA 
genes. NZH is a strain of NZ HF with a high Breeding Worth in the 1990s. 
The strain represented NZ selection and breeding policies used in the 
1990s (high milk production) and had 24% NA HF genetics. OSH is a 
strain of HF from North America, which also had a high Breeding Worth in 
the 1990s. NZ born cows with a high proportion of NA genetics were bred 
with sires of primarily NA origin to generate this strain. These sires were 
commonly used within NZ in the 1990s because of their high protein and 
milk estimated breeding value. The OSH strain had 91% NA HF genetics.  
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2.2.2. Sample Collection 
 
Pregnant Holstein cows from the three strains (NZL n=12, NZH 
n=28, OSH n=30) were assigned to have blood samples taken at weekly 
intervals and a biopsy sample (up to 200 mg) taken under anaesthesia 
from the trapezius muscle at -1, 1, 4, 8, 12 weeks post-calving (1-12 
weeks being peak lactation). A blood sample (10 mL) was obtained by 
jugular venepuncture into vacutainer tubes containing heparin as 
anticoagulant. Tubes were centrifuged at 1500 x g for 10 min to separate 
red blood cells and plasma, and the plasma was then harvested and 
stored at -80 °C for later determination of creatine kinase (CK), and for 
Western analysis to detect levels of troponin I-fast skeletal. Biopsy 
samples were taken from the trapezius muscle and snap frozen in liquid 
nitrogen and stored at -80 °C. This study was approved by the Dexcel 
Animal Ethics Committee (#10586). 
 
2.2.3. Analysis of Creatine Kinase, Troponin and Myostatin in  
Plasma 
Plasma was stored at -80 °C until required. Plasma CK was 
measured in duplicate (n=9 animals per strain) using the CK NAC-
activated assay (RANDOX Laboratories Ltd., Antrim UK) as per 
manufacturer’s instructions. For determination of troponin and myostatin, 
two μL plasma for each time point was mixed with Laemmli loading buffer 
(Laemmli, 1970), boiled for 5 min, then loaded and separated in a sodium 
dodecyl sulfate-polyacrylamide (SDS-PAGE) gel under reducing 
conditions (12% acrylamide for troponin, 15% for myostatin). Proteins 
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were then transferred to a BioTrace NT nitrocellulose membrane (PALL 
Corporation). After transfer, membranes were stained with Ponceau S to 
verify transfer of protein. Membranes were blocked (0.3% BSA, 1% PEG 
and 1% PVP, and 0.01% Thimerosal) for 2 hours at room temperature. 
Initially, four antibodies were titred for troponin to determine which troponin 
isoform was most appropriate to measure. The four antibodies titred were 
rabbit polyclonal troponin I fast skeletal (I-fs) (Santa Cruz 20644), I slow 
skeletal (I-ss) (Santa Cruz 20645), T-fs (Santa Cruz 20643) and T-ss 
(Santa Cruz 28269). Half-log dilutions from 1:1000 to 1:30 000 were tested 
with various animals. The antibodies used for plasma analysis were rabbit 
polyclonal troponin I-fs diluted 1:3000 (selected because it had the most 
distinctive band) and goat polyclonal myostatin (Santa Cruz 6884) 1:3000 
diluted in blocking buffer. Membranes were incubated with primary 
antibody overnight at 4 ˚C on a shaking table. After overnight incubation, 
membranes were then washed several times in 0.02 M Tris buffered saline 
with 0.1% Tween 20 (TBST, pH 7.6), then incubated with horseradish 
peroxidase (HRP)-conjugated secondary antibody (rabbit polyclonal goat 
(Dakocytomation P0448) or goat polyclonal rabbit (Dakocytomation 
P0449), diluted 1:5000 in blocking buffer) for 2 hours. Membranes were 
then washed several times with TBST followed by repeated washes with 
TBS, to rinse off any traces of Tween 20 which interferes with the 
peroxidase reaction. Bound HRP activity was detected with enhanced 
chemiluminescence for 4 min and then blots were exposed to BioMax 
XAR film (Eastman Kodak Company, Rochester, NY). The density of each 
protein band detected was determined using a densitometer (Bio-Rad 
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Laboratories Pty., Ltd., Auckland, New Zealand) and analysed using 
Quantity One software (Bio-Rad Laboratories).  
To validate that concentrations of troponin are reliable markers of 
muscle wasting, plasma from rats that were inoculated with the AH130 
tumour was separated on 12% SDS-PAGE gels as per above and the 
same panel of troponin antibodies was screened to determine the 
appropriate antibody to use and the optimal titre. Briefly, male Sprague-
Dawley rats (3 months old) were injected i.p. with 100 μL of sterile saline 
(n=6), or 100 μL of freshly passaged ascites (n=6) from a donor rat with 
the AH130 tumour (Baracos et al., 1995). Rats were killed at 6 days and 
blood was obtained by cardiac puncture and the plasma harvested. Body 
mass was recorded and the Tibialis anterior  muscle (a representative fast-
twitch muscle known to undergo wasting during AH130-induced cancer) 
was excised and weighed and corrected to percent of body mass of rats 
on day 0. This study was approved by the Ruakura Animal Ethics 
Committee (#4113). 
 
2.2.4. Myosin Heavy Chains 
 
MHCs were extracted (Seward et al., 2001) and between 1 and 
1.5 μg of crude protein from each muscle sample was loaded and 
separated in a SDS-PAGE gel under reducing conditions and stained with 
Coomassie blue (Talmadge and Roy, 1993). The optical density of each 
MHC band was determined using a densitometer (Bio-Rad Laboratories) 
and analysed using Quantity One software (Bio-Rad Laboratories). 
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2.2.5. RNA Extraction and Analysis 
 
Because not all tissue samples were available for each sample 
time, a representative nine were selected that comprised the most 
complete set available for the sample times. Frozen muscle samples 
(30-120 mg) were homogenized on ice in Trizol Reagent (Invitrogen) for 
30 sec at 13,500 rpm using an Ultra Turrax homogenizer. Debris was 
removed by centrifugation for 10 min at 10,000 x g and total RNA was 
isolated using the Trizol protocol (Invitrogen). RNA was re-suspended in 
0.1% DEPC-treated water and the final concentration determined by 
measuring absorbance at 260 nm.  Total RNA (2.4 µg) from each sample 
was reverse transcribed using oligo (dT) primers and Superscript III 
reverse transcriptase (Invitrogen) according to manufacturer’s instructions. 
The reverse transcribed (RT) reactions were then diluted 100-fold for 
quantification of Atrogin-1 (atro1), Muscle ring-finger protein 1 (murf1), and 
cathepsin B, D, H and L mRNA levels.  Real-time PCR was carried out 
using the Roche Lightcycler 2.0 with 2.5 μL of the diluted RT reaction and 
7.5 µL of the mastermix (2.0 µL Roche Faststart DNA master PLUS SYBR 
Green I mix, 4.0 µL water, 0.5 µL gene specific Primer 1 and 0.5 µL gene 
specific Primer 2).  Information on the primers used can be found in Table 
2.2. The reaction conditions were as follows: Denature for 5 min at 95°C, 
followed by 40 cycles of 95 ºC for 5 sec, 60 ºC for 10 sec and 72 ºC for 
20 sec. Standard curves were generated for correlation of sample 
concentrations. Melt curves were examined to ensure a single cDNA 
species was being amplified for each gene under investigation. Products 
were run out on a 1% agarose gel to confirm a single species was 
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amplified. All primers were designed using Vector NTI (Invitrogen) and 
made by SIGMA Genosys. Results for each sample were corrected to total 
single-stranded cDNA using the Quant-iT OliGreen ssDNA assay Kit as 
per manufacturer’s instructions (Molecular Probes, Inc. OR, USA) (Lundby 
et al., 2005). 
 
2.2.6. Protein Extraction and Analysis 
 
Six representative animals were selected at random from each 
strain for analysis of total and phosphorylated p70S6K, eIF2α, eIF4E and 
4E-BP1. One ml of ice cold low salt lysis buffer (10 mM Hepes, 5 mM KCl, 
10 mM MgCl, pH 7.9) with 0.1 mM EDTA, 0.5% IGEPAL detergent (Sigma 
Chemical Co. St. Louis, MO, USA), 0.5% Vanadate and an enzyme 
inhibitor (Complete, Roche Diagnostics NZ Ltd., Auckland, New Zealand) 
was added to muscle (30-120 mg) from each animal. Samples were 
homogenised on ice, then centrifuged at 11,000 xg for 10 min. 
Supernatant was recovered, mixed with Laemmli loading buffer (Laemmli, 
1970), boiled for 5 min, then stored at –20 °C until analysis. The protein 
concentration of the supernatant was determined using the bicinchoninic 
acid assay (Sigma Chemical Co.). 
Twenty μg of protein from each muscle sample was loaded and 
separated in a SDS-PAGE gel under reducing conditions (8% acrylamide 
for p70S6K, 10% for eIF2α and 15% for 4E-BP1), then transferred to a 
BioTrace NT nitrocellulose membrane (PALL Corporation). After transfer, 
membranes were stained with Ponceau S to verify transfer of protein. 
Membranes were blocked (0.3% BSA, 1% PEG and 1% PVP, 0.01% 
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Thimerosal) for 2 hours, and then incubated with one of the following 
specific antibodies diluted in blocking buffer: rabbit monoclonal 4E-BP1 
(Cell Signaling 9452) diluted 1:1000, rabbit polyclonal phospho-4E-BP1 
(Cell Signaling 2855) diluted 1:5000, rabbit polyclonal eIF2α (Santa Cruz 
11386) diluted 1:5000, rabbit polyclonal phospho-eIF2α (Sapphire 
Bioscience AB4837) diluted 1:3000, rabbit polyclonal eIF4E (Santa Cruz 
13963) diluted 1:3000, rabbit polyclonal phospho-eIF4E (Santa Cruz 
12885R) diluted 1:3000, rabbit polyclonal p70S6K (Cell Signaling 9202) 
diluted 1:3000, rabbit polyclonal phospho-p70S6K (Santa Cruz 7984R) 
diluted 1:3000 and rabbit polyclonal α–actin (Sigma Chemical Co.) diluted 
1:5000. After overnight incubation at 4 ˚C, membranes were then washed 
several times in 0.02 M Tris buffered saline with 0.1% Tween 20 (TBST, 
pH 7.6), then incubated with HRP-conjugated secondary antibody, rabbit 
polyclonal goat (Dakocytomation P0449) or goat polyclonal rabbit 
(Dakocytomation P0448), diluted 1:5000 in blocking buffer) for 2 hours. 
Membranes were then washed several times with TBST followed by 
repeated washes with TBS, to rinse off any traces of Tween 20 which 
interferes with the peroxidase reaction. Bound HRP activity was detected 
with enhanced chemiluminescence for 4 min and then blots were exposed 
to BioMax XAR film (Eastman Kodak Company). The density of each 
protein band detected was determined using a densitometer (Bio-Rad 
Laboratories) and analysed using Quantity One software (Bio-Rad 
Laboratories). 
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2.2.7 Statistical Analysis 
 
Troponin I-fs and myostatin were assessed in a representative 8 animals 
for each strain at -1, 1, 2, 3, 4, 8, and 12 weeks postpartum. Myosin heavy 
chains were assessed in a representative 6 animals for each strain at -1, 4 
and 12 weeks postpartum. Atro1 and murf1 were assessed in a 
representative 9 animals for each strain at -1, 1, 4, 8, and 12 weeks 
postpartum. Cathepsin B, D and H were assessed in a representative 9 
animals for each strain at -1, 1, 4 and 12 weeks postpartum. Protein 
analysis was carried out on a representative 6 animals for each strain at    
-1, 1, 4, 8 and 12 weeks postpartum. All data was analysed using a 
repeated-measures ANOVA. Post-hoc comparison analyses among 
groups were performed using a Tukey test. Data are presented as 
means ± standard error (s.e.m.). 
3. Results 
3.1. Previously Published Data on NZL, NZH and OSH cows  
 Milk yield, BWT, BCS and concentrations of NEFAs in plasma have 
been recorded previously for the three strains of cow in this study. The 
NZL cows exhibit a low milk yield, the NZH cows intermediate, and the 
OSH cows high (McDonald et al. 2007). In previous studies, OSH high 
cows have a higher BWT than the NZL and NZH cows, and they lose more 
BWT throughout lactation (McDonald et al. 2007; Chagas et al. 2006). 
OSH cows typically have a lower BCS throughout lactation than the NZL 
and NZH cows. Studies have shown concentrations of NEFAs in plasma 
increase during the first two weeks of lactation, and then steadily decrease 
(Guo et al. 2007; Roche et al. 2007). Concentrations of NEFAs in plasma 
were lower in NZL and NZH cows than in OSH cows (Roche et al. 2007). 
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3.2. Plasma Analyses 
3.2.1. Creatine Kinase 
Elevated concentrations of CK in plasma are often indicative of 
breakdown of muscle and CK detection has been used to assess skeletal 
muscle damage or injury caused by rigorous exercise or disease-induced 
muscle wasting (see section 1.7.2.). Concentrations of CK were 
unchanged in all strains over time, with the exception of being higher 
(P<0.01) in NZH cows than NZL and OSH cows at 8 weeks postpartum 
(Figure 3.1).  
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Figure 3.1: Creatine kinase in cow plasma. Mean (± s.e.m.) concentrations of creatine 
kinase in plasma of three strains of cow (NZL, NZH, OSH) (n=9 per strain) from -1 to 12 
weeks of lactation. 
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3.2.2. Troponin 
When muscle fibres undergo degradation, troponins are released 
into the blood. Skeletal muscle-specific troponins have recently become 
useful for detecting breakdown of muscle (see section 1.7.3.). Four 
antibodies were tested for abundance of troponin in plasma; troponin T-ss, 
troponin T-fs, troponin I-ss and troponin I-fs. The expected molecular size 
of troponin T is between 31 and 37 kDa. The expected molecular size of 
troponin I is 21 kDa. Of the troponin antibodies tested, only troponin I-fs 
consistently showed an immunoreactive band of the appropriate molecular 
weight (21 kDa) in cows (Figure 3.2). In rat plasma, again all four 
antibodies were tested and troponin I-fs had the most consistent 
immunoreactive band. However, the molecular size of the only 
immunoreactive band present was 13 kDa rather than the expected 
21 kDa (Figure 3.3 A). This molecular weight band represents one of 
several known breakdown products (Simpson et al., 2005; Simpson et al., 
2000; McDonough et al., 1999; Gao et al., 1997). Therefore, troponin I-fs 
was used to analyse plasma concentrations in cows and rats. 
Troponin I-fs was increased in plasma of cachectic rats 
(Figure 3.3 B) and this was associated with a decrease in mass of the 
Tibialis anterior (Figure 3.3 C). There was an overall effect of time 
(P<0.05), in which there was an increase in the abundance of troponin I-fs 
in plasma in all strains Figure 3.4 B), peaking at three weeks and 
remaining high (P<0.05) for the rest of the study, but no effect of peak 
lactation for individual strains of cow (Figure 3.4 C). Abundance of 
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troponin I-fs was higher in NZH than OSH (P<0.05) and NZL (P<0.001) 
cows demonstrating a clear effect of strain (Figure 3.5). 
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Figure 3.2: Detecting troponin isoforms in cow plasma. Titrations were done with 
dilutions from 1:1000, 1:3000 and 1:10 000 of (A) troponin T-ss, T-fs, and (B) troponin 
I-ss and I-fs to measure troponin in plasma. Shown is the 1:3000 titre of these antibodies 
to demonstrate that only troponin I-fs shows a specific immunoreactive band at 21 kDa. 
The expected molecular weight of troponin T is 31-37 kDa. No band was detected using 
either troponin T antibody. 
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Figure 3.3: Troponin I-fs in AH130 rats. (A) Troponin I-fs detected in plasma of adult 
male rats subjected to vehicle (C) or AH130 tumour by Western blot. Band was detected 
at 13 kDa, representing one of several breakdown products of troponin I-fs. 
(B) Abundance of Troponin I-fs in plasma for control rats (C) and rats at six days with 
tumour. (C) Percent loss of muscle in TA of AH130 rats compared to controls corrected to 
body weight at the start of the experiment (n=6). Asterisk indicates significant difference 
from controls (** P<0.01 , *** P<0.001). 
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Figure 3.4: Troponin I-fs in cow plasma. (A) Single band at approximately 21 kDa 
representing troponin I-fs in NZH 941 from -1 to 12 weeks of lactation. (B) Effect of time 
alone (pooled mean ± s.e.m.) of troponin I-fs in plasma for all three strains (n=9 per 
strain) from -1 to 12 weeks of lactation. (C) Mean (± s.e.m.) of troponin I-fs in plasma from 
-1 to 12 weeks of lactation for each strain (n=9 per strain).  
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Figure 3.5: Abundance of troponin I-fs in plasma of the three different strains of cow. 
Effect of strain (pooled mean ± s.e.m., n=9 per strain) on troponin I-fs in plasma from one 
week before calving to 12 weeks postpartum for each strain. Asterisk indicates a 
significant difference among strains (***P<0.001 ). 
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3.2.3. Myostatin 
Myostatin expression increases in various conditions of atrophy. An 
increase in the abundance of myostatin in plasma could support loss of 
muscle due to breakdown (see section 1.6.2.). Myostatin was detected in 
plasma at 26 kDa (Figure 3.6 A), which is the expected molecular weight 
of the mature myostatin peptide dimer. The optical density of mature 
myostatin did not change over the period of study for any of the three 
strains (Figure 3.6 B). However, there was an effect of strain (P<0.001), 
whereby OSH cows had a lower abundance of myostatin consistently 
detected in plasma. 
 45
 Weeks Postpartum
0 2 4 6 8 10 12
O
pt
ic
al
 D
en
si
ty
6
8
10
12
14
16
18
NZL 
NZH 
OSH 
37
25
20
-1          1           2           3           4          8     12                     
A.
B.
Mature 
peptide 
dimer
O
pt
ic
al
 D
en
si
ty
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Myostatin in cow plasma.  (A) A single immunoreactive band detected at 
26 kDa representing mature myostatin dimer in NZH 2078 plasma samples taken at -1 to 
12 weeks of lactation. (B) Mean (± s.e.m.) abundance of mature myostatin peptide in 
plasma from -1 to 12 weeks of lactation in all three strains. There is a significant effect of 
strain whereby OSH cows have a lower abundance of plasma myostatin (P<0.001). 
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3.3. Fibre Typing 
3.3.1. Myosin Heavy Chains 
The breakdown of muscle is often accompanied by changes in the 
abundance of MHC isoforms (see section 1.7.1.). These changes can be 
observed through SDS-PAGE separation of crude muscle samples. For 
each time point for each animal, two distinct bands could be seen in the 
Coomassie-stained gels (Figure 3.7 A). The upper band represents 
skeletal muscle fibre type IIx and the lower represents type I. There was 
an effect of strain whereby OSH cows had more type II than NZL and NZH 
cows (P<0.05). However, there was no overall effect of time of lactation, or 
effect of individual strain during peak lactation, on relative abundance of 
MHCs (Figure 3.7 B). 
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Figure 3.7: Myosin heavy chains in cow trapezius muscle. (A) MHC isoforms in trapezius 
muscle from NZH 9971 separated by SDS-PAGE and stained with Coomassie blue. 
Samples from one week before calving, and at four and 12 weeks postpartum. Soleus 
and plantaris samples were run for comparative purposes. (B) Mean (± s.e.m.) 
percentage of type IIx in trapezius muscle samples at -1, 4 and 12 weeks postpartum. 
There is a significant effect of strain whereby OSH have a higher percent of type IIx 
compared with either NZL or NZH (P<0.05). 
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3.4. RNA Analysis 
Breakdown of muscle may be the result of an increase in protein 
degradation. The two key degradative pathways primarily responsible for 
protein degradation are the UbP pathway and the lysosomal pathway.  
 
3.4.1. The Ubiquitin-Proteasome Pathway 
The UbP ligases atro 1 and murf 1 are consistently upregulated in 
several conditions of muscle atrophy and are widely used as markers of 
muscle wasting (see section 1.5.4.1.). An increase in expression of atro 1 
and murf 1 mRNA would suggest that breakdown of muscle is occurring 
through an increase in degradation. An effect of time was seen whereby 
there was a tendency for Atro1 to increase (P<0.1), then concentrations of 
Atro1 decreased by week four (P<0.01) and remained low for the rest of 
the study (Figure 3.8 A). There was no effect of strain on atrogin mRNA. A 
similar pattern was observed for Murf1 (Figure 3.8 B) with concentration 
increased from week -1 to week 1 of lactation, after which time the 
concentration of Murf1 mRNA decreased and remained low for the rest of 
the study (P<0.001). 
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Figure 3.8: Analysis of ubiquitin proteasome E3 ligases Atro1 and Murf1 mRNA by 
real-time PCR. Mean arbitrary concentrations (± s.e.m.) of (A) Atrogin and (B) Murf1 
mRNA expression in NZL, NZH and OSH from one week before calving to 12 weeks 
postpartum. There was an increase in expression of both genes from -1 to 1 week of 
lactation (at least P< 0.1).  
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3.4.2. The Lysosomal Pathway 
Lysosomal degradation is a second pathway contributing to muscle 
degradation. The cathepsins are lysosomal proteases which are 
upregulated in conditions of muscle wasting (see section 1.5.4.3.). 
Cathepsin L mRNA was very low in abundance and could not be amplified 
to a measurable concentration (data not shown). An effect of time was 
seen whereby concentrations of cathepsin B mRNA decreased from -1 to 
4 weeks postpartum (P<0.01) (Figure 3.9 A), and cathepsin D mRNA 
decreased from -1 to 1 weeks of lactation in NZL and NZH cows (P<0.05) 
(Figure 3.9 B). The level of cathepsin H mRNA was greater in NZH cows 
at 12 of lactation (P<0.001) (Figure 3.9 C).  
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Figure 3.9: Analysis of Cathepsin mRNA by real-time PCR. Mean arbitrary 
concentrations (± s.e.m.) of (A) cathepsin B, (B) cathepsin D and (C) cathepsin H mRNA 
expression in NZL, NZH and OSH from one week before calving, 4 and 12 weeks 
postpartum.  
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3.5. Protein Analysis 
 
 Breakdown of muscle could also be the result of a decrease in 
protein synthesis. To determine whether or not protein synthesis was 
being downregulated, the components of translation initiation were 
investigated. 
 
3.5.1. p70S6K 
The phosphorylation of p70S6K protein correlates with an increase 
in protein synthesis (see section 1.5.3.). Therefore, it was expected that 
the ratio of phosphorylated p70S6K over total p70S6K would decrease 
over the period of study, representing a decrease in protein synthesis. 
Two antibodies were tested for total p70S6K and two for 
phospho-p70S6K. Out of the four tested, only one antibody for total 
p70S6K gave a single specific band at 70 kDa. Both antibodies for the 
phosphorylated state of p70S6K gave multiple immunoreactive bands at 
varying molecular weights (see Appendix A and B). No band was detected 
at the expected 70 kDa size for phosphorylated p70S6K, therefore the 
antibody was probably not specific for cows. 
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3.5.2. eIF2α 
The eIF2 complex, made up of eIF2α and eIF2β, controls the 
association of the initiator methionyl-transfer RNA to the native 40S 
ribosome, forming the 43S initiator complex (see section 1.5.3.). Upon 
phosphorylation, eIF2α binds eIF2β very tightly and prevents the catalytic 
activity of eIF2β, thereby downregulating protein synthesis. It was 
expected that the ratio of phosphorylated over total eIF2α would increase 
over the period of study, in order to decrease the amount of protein 
synthesis taking place. One antibody was tested for total eIF2α and one 
for phospho-eIF2α. A distinct band at the expected molecular weight of 
approximately 37 kDa was seen for each antibody (Figure 3.10 A). There 
was no change in eIF2α total or phosphorylated for any of the three strains 
(Figure 3.10 B and C). The ratio of phosphorylated eIF2α over total eIF2α 
was greater in NZL cows (P<0.001) compared with NZH and OSH, but 
there was no effect of lactation on this ratio (Figure 3.10 D). 
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Figure 3.10: Phosphorylated and total eIF2α in cow muscle. (A) A single band 
representing eIF2α detected at 37 kDa the trapezius muscle of OSH 1792 at -1 to 12 
weeks of lactation. (B) Mean (± s.e.m.) abundance of phosphorylated eIF2α in all three 
strains (n=6 per strain) from -1 to 12 weeks of lactation. (C) Mean (± s.e.m.) abundance 
of total eIF2α in all three strains from -1 to 12 weeks of lactation. (D) The ratio of 
phosphorylated eIF2α over total for all three strains from -1 to 12 weeks of lactation. NZL 
has a higher ratio than NZH and OSH cows for phosphorylated eIF2α over total eIF2α 
(P<0.001). 
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3.5.3. eIF4E 
The eIF4 factors assist mRNA with binding to the 43S initiation 
complex, to form the 48S initiation complex. Phosphorylation of eIF4E 
allows association with eIF4G, which in turn allows recruitment of several 
other initiation factors, which leads to initiation of cap-dependent protein 
synthesis (see section 1.5.3.). It was expected that protein synthesis is 
downregulated. Therefore, the ratio of phosphorylated over total eIF4E 
was expected to decrease over the course of the study. Two antibodies 
were tested for total eIF4E and one for phospho-eIF4e. Both antibodies for 
the phosphorylated state of eIF4E gave multiple immunoreactive bands at 
varying molecular weights (see Appendix A). No band was detected at the 
expected 25 kDa size, therefore the antibody was probably not specific for 
cows. 
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3.5.4. 4E-BP1 
Translation initiation via eIF4E is inhibited when eIF4E is bound to 
4E-BP1. Phosphorylation of 4E-BP1 causes dissociation of the two 
proteins, consequently allowing the upregulation of protein synthesis via 
eIF4E (see section 1.5.3.). For the current study, it was expected that the 
ratio of phosphorylated over total 4E-BP1 would increase over time, 
thereby downregulating protein synthesis. Two antibodies were tested for 
total 4E-BP1 and two for phospho-4E-BP1. One antibody for total and one 
for phosphorylated gave the expected immunoreactive bands. The other 
two antibodies showed various non-specific bands (see Appendix B). Two 
bands were present at the expected molecular weight of 4E-BP1, between 
15-20 kDa, for both total and phosphorylated 4E-BP1 (Figure 3.11 A). 
There was no change in total or phosphorylated 4E-BP1 for any of the 
three strains (Figure 3.11 B and C). The ratio of phosphorylated 4E-BP1 
over total 4E-BP1 also did not show any change among strain or over the 
period of study (Figure 3.11 D). 
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Figure 3.11: Phosphorylated and total 4E-BP1 in cow muscle. (A) A double band 
representing 4E-BP1 detected at approximately 12 kDa in the trapezius muscle of OSH 
1982 at -1 to 12 weeks of lactation. Positions of differentially migrating forms of 4E-BP1 
(α and β) are shown on the right of the blot. (B) Mean (± s.e.m.) abundance of 
phosphorylated 4E-BP1 in all three strains (n=6 per strain) from -1 to 12 weeks of 
lactation. (C) Mean (± s.e.m.) abundance of total 4E-BP1 in all three strains from -1 to 12 
weeks of lactation. (D) The ratio of phosphorylated 4E-BP1 over total for all three strains 
from -1 to 12 weeks of lactation. 
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4. Discussion 
Three different strains of cow were analysed during this study. The 
NZL strain represents a strain of cow from earlier than 1970, when the milk 
production demand was lower and milk fat content was higher. This strain 
had only 7% NA HF genetics. The NZH strain represents cows with high 
Breeding Worth from after 1990, by which time milk production demands 
were much higher. This strain had 24% NA HF genetics. The OSH strain 
represents HF cows from NA, with 91% NA genetics. These cows were 
born in NZ; however, both sires and dams had a high proportion of NA 
genetics. This strain represented the high milk-producing, high energy 
grain-fed cows of the NA dairy industry.  
The key objective of this study was to determine if breakdown of 
skeletal muscle occurs in lactating dairy cows, and whether breakdown 
occurred to a greater extent in the OSH strain than the NZL and NZH 
strains. 
Previous studies have shown a loss in BWT and a loss in BCS with 
a corresponding increase in NEFAs in HF cows fed on pasture or grains, 
for several weeks postpartum (Adewuyi et al., 2005; Emery et al., 1992; 
Pushpakumara et al., 2003). Currently, it is thought that breakdown of fat 
helps cows maintain EB during peak lactation. Increased concentrations of 
NEFAs in plasma are consistent with mobilisation of lipid to help offset the 
increased energy demand of lactation. However, concentrations of NEFAs 
eventually stabilise while BCS and BWT remain low. Food intake does 
increase, but not enough to supply the cow with the energy required to 
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sustain lactation (Bauman & Currie, 1980; Forbes, 1970). If cows remain 
in a state of negative EB, other tissues must be mobilised to help meet the 
cow’s energy requirements. It is unclear whether fat mobilisation, in 
conjunction with increased food intake, accounts for the restoration of 
energy balance. Previous studies examine the diameter of the 
Longissimus dorsi pre- and postpartum, which decrease together with a 
decrease in BWT and BCS (Bruckmaier et al., 1998; Jaurena et al., 2005). 
However, the role of muscle breakdown during peak lactation has not 
been determined.   
Troponins have skeletal and cardiac specific isoforms. Troponin I-fs 
has been used for detecting breakdown of skeletal muscle after exercise-
induced injury, and in soft-tissue injuries (Onuoha et al., 2001; Sorichter et 
al., 1997). Four skeletal muscle specific troponin isoforms were tested, 
and troponin I-fs gave the strongest immunoreactive signal in plasma of 
rats and cows. 
The main finding in the current study was that the abundance of 
troponin I-fs in plasma increases and remains high from 3 to 12 weeks of 
lactation, supporting the hypothesis that there is a breakdown of skeletal 
muscle. Therefore, breakdown of skeletal muscle may contribute 
substrates to help restore EB in conjunction with lipolysis and an increase 
in appetite during peak lactation in cows.  
The amount of troponin I-fs in cow plasma increased to over twice 
the normal level within 3 weeks postpartum and remained elevated, for the 
duration of the study. This finding suggests that breakdown of skeletal 
muscle is occurring during peak lactation. Furthermore, there was a 
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significant difference in the level of plasma troponin between the NZL and 
NZH strains independent of lactation. Troponin was three times more 
abundant in the NZH cows. The OSH cows displayed an intermediate 
level of troponin, suggesting that breakdown of muscle was occurring 
during the sampling period and, collectively, these data suggest that the 
level of breakdown was greater in the strains selected for high milk 
production. 
Measurement of troponins have replaced creatine kinase assays in 
the clinical environment to help diagnose acute myocardial infarct as they 
are more sensitive and tissue specific (Apple, 1999a, 1999b; Apple et al., 
1997). Creatine kinase is expressed in cardiac and skeletal muscle. 
Therefore, the origin of CK detected in blood is unclear (Apple, 1999a, 
1999b; Jaffe et al., 2000). The creatine kinase assay used in this study 
failed to show any consistent changes for all strains of cow over time. For 
this reason, the abundance of skeletal specific troponin I-fs was 
measured. The current study supports the view that assay of troponin I-fs 
is a more sensitive marker of muscle breakdown than that of CK. 
In this study the mass of specific muscles could not be measured. 
Consequently, plasma from rats with the AH130 tumour was analysed to 
verify that a decrease in muscle mass correlates with an increase in 
plasma troponin. The rat Tibialis anterior obtained 6 days after injection 
with AH130 showed a significant decrease in muscle mass compared with 
the control rats injected with saline. Again troponin I-fs gave the strongest 
signal. However, the immunoreactive band was at 13 kDa, rather than the 
expected 21 kDa. This molecular weight band represents one of several 
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known breakdown products (Simpson et al., 2005; Simpson et al., 2000; 
McDonough et al., 1999; Gao et al., 1997). As a result, the abundance of 
this signal was taken to reflect the changes in the level of troponin I-fs in 
blood. The increased abundance of troponin I-fs in rat plasma coincided 
with the decrease in muscle mass observed, compared with controls. 
Therefore, we were confident in the use of troponin I-fs to examine the 
breakdown of muscle in cows during peak lactation. However, another 
more specific antibody will need to be used to confirm this finding. 
The composition of MHCs is useful to detect the loss of specific 
fibre types (Pette & Staron, 2000; Tisdale, 1999). There was no significant 
change in the abundance of any MHC, which suggests that breakdown 
may not be limited to a particular fibre type. However, the pattern did 
suggest that there is a decrease in MHC type IIx in NZH cows from one 
week before calving to 12 weeks postpartum. It is also possible that other 
muscles undergo wasting to contribute to the increase in troponin I-fs in 
plasma. 
Given that increased troponin I-fs in plasma suggests that 
breakdown of muscle occurs during peak lactation, it would be expected 
that expression of the components of various proteolytic pathways would 
increase. In several types of muscle wasting, including cachexia, HIV, 
sepsis, and immobilisation, mRNA of the two main E3 ligases of the UbP 
pathway (atro1 and murf1) consistently increase (Cao et al., 2005; Eley & 
Tisdale, 2007; Glass, 2005; Szewczyk & Jacobson, 2005). In the current 
study, atro1 and murf1 increased from immediately after calving to four 
weeks postpartum, after which the concentrations of mRNA decreased 
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and remained low for the rest of the study. Therefore, upregulation of the 
UbP pathway is consistent with the breakdown of skeletal muscle during 
the first four weeks of lactation. However, the abundance troponin I-fs 
remained high throughout the study, until 12 weeks postpartum, despite 
the restoration of atro1 and murf1 mRNA to control levels at four weeks of 
lactation. Consequently, the proteins encoded by these genes are either 
long-lived and are functional long after transcription has ceased, or 
another mechanism contributes to the continued breakdown of muscle. 
Cathepsins are proteases which execute degradation via the 
lysosomal pathway. It was expected that the cathepsin (B, D, H and L) 
mRNA concentration would increase during the course of this study. 
Cathepsin L, which is considered the general marker of atrophy, was 
undetectable. Cathepsin B, D and H mRNA concentrations did not 
increase in any strain throughout the period of the study with an isolated 
exception. The NZH strain showed a higher concentration of cathepsin H 
mRNA at week 12. However, since cathepsins B, D and H remained 
constant over the period of study, and cathepsin L was undetected, it is 
highly probably that the lysosomal pathway is not contributing significantly 
to the breakdown of muscle in NZL, NZH and OSH cows.  
It is possible that since the UbP pathway is upregulated for the first 
four weeks, the lysosomal pathway is unaffected to allow for only limited 
degradation during this time. In disease states such as cachexia, 
immobilization, sepsis and HIV, significant breakdown of muscle takes 
place (Lecker et al., 1999; Tisdale, 2005). Given that lactation is not a 
disease-induced state, induction of large amounts of muscle degradation 
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might not be expected, as this may be detrimental to the animal’s health. 
Therefore, it is not unreasonable that one degradative pathway be 
upregulated, temporarily, while another remains constant.  
The calpains, components of the Ca2+-dependent degradation 
pathway, were not examined, as they work in conjunction with the UbP 
and lysosomal pathways and are responsible for only limited degradation. 
The calpains initiate myofibrillar degradration, while the UbP and 
lysosomal pathways complete the degradation (Bartoli & Richard, 2005; 
Costelli et al., 2005; Koohmaraie, 1992; Solomon & Goldberg, 1996; 
Williams et al., 1999). The early upregulation of the UbP pathway 
components most likely accounts for the breakdown of muscle during the 
first four weeks of lactation. 
The phosphorylation state of the various components of translation 
initiation determines the rate of protein synthesis. It was expected that 
there would be a decrease in protein translation in lactating cows. For this 
to occur, the ratio of phosphorylated eIF2α over total eIF2α should 
increase over time such that more eIF2α is phosphorylated. The ratio of 
phosphorylated 4E-BP1 over total 4E-BP1, on the other hand, should 
decrease over time, since unphosphorylated 4E-BP1 inhibits protein 
synthesis. The phosphorylation of p70S6K increases the rate of synthesis. 
Therefore it was expected that the ratio of phosphorylated p70S6K over 
total p70S6K would decrease with time resulting in a decrease in 
translation initiation. 
While the ratio of phosphorylated over total protein for p70S6K 
could not be assessed, the ratio of phosphorylated over total protein for 
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4E-BP1 was not significantly different between strains or over time. 
Phosphorylated over total eIF2α did not show any change over time in 
NZH and OSH cows. However, the ratio was greater in NZL cows, which 
suggests that there is less synthesis taking place in this strain, although 
there was no effect of lactation. Only eIF2α and 4E-BP1 could be detected 
reliably and these two components of the protein synthesis pathway 
showed no change in the relative abundance of phospho- to total protein 
for NZH and OSH cows. Therefore, these data suggest that the increase 
in abundance of troponin I-fs in plasma occurring in cows from 3 weeks to 
12 weeks postpartum is not due to a decrease in protein synthesis in 
trapezius muscles of lactating cows.  
Myostatin is a growth factor regulating myogenesis (McCroskery et 
al., 2003; Taylor et al., 2001). It has also been shown to play a role in 
muscle wasting (Zimmers et al., 2002). Myostatin expression increases in 
conditions of atrophy such as during muscle disuse and in HIV-infected 
men (Carlson et al., 1999; Gonzalez-Cadavid & Bhasin, 2004; Lalani et al., 
2000; Ma et al., 2003). In the present study it was expected that there 
would be an increase in circulating myostatin in all strains of cow and that 
the levels of myostatin might be greater in those strains in which greater 
muscle wasting was indicated. Although there was an effect of strain, 
whereby the OSH cows had significantly less myostatin detected in 
plasma than the NZL and NZH cows, there were no significant changes in 
the abundance of myostatin in plasma over time in any of the three strains, 
suggesting that myostatin does not play a role in the breakdown of muscle 
during peak lactation. However, the lower abundance of myostatin in the 
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larger OSH cows is consistent with less inhibition of post-natal growth, 
thereby allowing an increase in body and muscle mass compared with 
NZL and NZH cows. 
 It was expected that the NZL cows would weigh less, have less of a 
decrease in BCS, produce less milk and therefore have less breakdown of 
muscle. Several findings in this study supported that suggestion. The NZL 
cows did weigh less, they produced less milk and their BCS remained 
unchanged (Dexcel unpublished data). Troponin I-fs was least abundant in 
plasma of the NZL cows over the 12 weeks postpartum, suggesting that 
muscle breakdown was occurring to a lesser extent in the NZL cows than 
the NZH and OSH cows. The OSH strain was expected to weigh more, 
have a greater loss of BCS due to their high milk production and therefore 
have greater breakdown of muscle taking place. The OSH cows in this 
study did weigh more, had higher milk yield, and lost more body condition 
over the 12 weeks postpartum (Dexcel unpublished data). An intermediate 
abundance of troponin I-fs was seen in plasma. OSH cows had a 
consistently lower level of myostatin detected in plasma throughout the 
study, lower than that detected in the plasma of either NZL or NZH cows. 
Although the abundance of troponin I-fs in plasma from OSH cows was 
higher than that of NZL cows, none of the results indicate that the OSH 
cows undergo breakdown of muscle to a greater degree than the NZH 
cows. The NZH cows represented a hybrid of NZ and NA cows. The 
genetic composition of NZ cows has changed over the past 20 years due 
to the use of NA HF semen (Harris & Kolver, 2001). However, having only 
24% NA genetics, the cows were expected to be intermediate in weight, 
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have intermediate milk yields, and have intermediate loss of body 
condition. It was expected that NZH cows would have had a breakdown of 
muscle occurring somewhere in between NZL and OSH cows. Indeed, the 
NZH cows had BWTs in between those of the NZL and OSH cows. The 
NZH cows had higher BCS initially, but lost body condition, to a similar 
extent as OSH cows. Interestingly, the NZH had the highest abundance of 
troponin I-fs detected in plasma over the 12 weeks postpartum. This 
suggests that the breakdown of muscle occurs to the greatest extent in 
NZH cows, perhaps to provide more substrates to help restore EB. 
The source of troponin I-fs remains unclear. The amount of atrophy 
occurring in a muscle depends on the function of the muscle. A muscle 
with stabilising function (i.e. the quadriceps) will undergo atrophy to a 
greater extent than one with an antagonist function (i.e. the hamstrings) in 
conditions of disuse (Kasper et al., 2002). Studies have shown that 
longissimus dorsi diameter and back fat thickness reflect changes in 
whole-body fat content as well as muscle mass in dairy cows (Bruckmaier 
et al., 1998; Otto et al., 1991; Pedron et al., 1993; Tamminga et al., 1997). 
Other studies use muscles involved with stabilisation or movement such 
as the soleus, the gastrocnemius or the quadriceps for detecting wasting 
(Lalani et al., 2000; Mancini et al., 1992; McMahon et al., 2003), and 
perhaps for comparative purposes any of those muscles may have 
provided more insight.  
In conclusion, the increased abundance of troponin I-fs in plasma 
suggests that muscle degradation occurs in lactating cows from three to 
12 weeks of lactation. Furthermore, the current study suggests that 
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breakdown of muscle can be attributed to the UbP pathway until four 
weeks of lactation, and that other, as yet unidentified processes, maintain 
the breakdown of muscle from four to 12 weeks postpartum. The 
abundance of troponin I-fs in plasma is greater in the NZH and OSH cows 
than the NZL cows, suggesting that breakdown of muscle may occur in 
relation to the yields of milk in the different strains of dairy cows. 
 Should investigation into the breakdown of muscle in lactating cows 
be further pursued, several changes may increase understanding of how 
this degradation is being mediated. The p70S6K and eIF4E antibodies 
used during this study produced either non-specific signals, or no signal. 
Assessing a wider range of antibodies specific for these factors of 
translation initiation could provide the information on protein synthesis 
missing from the current investigation. Superior information on troponin I-fs 
levels could be acquired with an enzyme-linked immunosorbant assay 
(ELISA) for troponin I-fs. Western blots provide semi-quantitative 
information on proteins. However, an ELISA would be a more sensitive 
and rapid method of obtaining quantitative results on troponin 
concentrations in blood.  
If this study were to be repeated, the muscle biopsied should be 
more carefully considered. A muscle that is commonly broken down during 
atrophy or one used to assess BCS would be a more suitable candidate. 
The study was not set up with a proper positive control. The cows were 
sampled at one week before calving to act as a positive control. However, 
it would have been preferable to also have 10 cows per strain that were 
not lactating for comparison with lactating cows. Unfortunately, the cost 
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per cow, as well as a requirement for ethics approval for an animal study 
renders the use of 30 extra cows implausible. Therefore, the information 
obtained from this study may not be an accurate representation of the role 
muscle plays during peak lactation, although it does provide sufficient 
evidence to suggest that muscle degradation is involved. 
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Appendix A: Titration one of antibodies to be used for investigating the components of 
protein translation initiation. 20 μg protein was loaded per well. The samples used were -1 
and 4 weeks postpartum. Nitrocellulose membranes were cut into strips with sample pairs. 
Antibodies were diluted 1:1000, 1:3000 and 1:10 000 to check strength and specificity.  
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Appendix B: Titration two of antibodies to be used for investigating the components of 
protein translation initiation. 20 μg protein was loaded per well. The samples used were -1 
and 4 weeks postpartum. Nitrocellulose membranes were cut into strips with sample pairs. 
Antibodies were diluted 1:1000, 1:3000 and 1:10 000 to check strength and specificity.  
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